Close X
Tuesday, November 26, 2024
ADVT 
International

Trump, after nod to loss, embraces his supporters

Darpan News Desk The Canadian Press, 08 Jan, 2021 06:37 PM
  • Trump, after nod to loss, embraces his supporters

Less than 24 hours after acknowledging his election loss, U.S. President Donald Trump is again urging grassroots supporters to keep the faith.

Trump, whose Twitter account was briefly frozen in the aftermath of the riots on Capitol Hill, finally admitted Thursday that he won't be president much longer.

But he's back tweeting this morning, promising his supporters they will continue to have a "giant voice" going forward and saying he won't attend the inauguration of Joe Biden.

The message comes with Trump's presidency, scheduled to end Jan. 20, now in real danger of ending even earlier.

Democrats enraged by Wednesday's riot, which they say Trump incited, are mobilizing to make him the first president in U.S. history to be impeached twice.

Media reports suggest Vice-President Mike Pence won't support their other option: a constitutional rule that allows an unfit commander-in-chief to be removed from office.

Trump vowed Friday that the 75 million "great American patriots" who voted for him in November would continue to be heard.

"They will not be disrespected or treated unfairly in any way, shape or form," he tweeted.

The message appears aimed at those members of his base who have expressed dismay at Trump's pledge to ensure an orderly transfer of power in 12 days.

Online forums popular with Trump supporters suggest some of them are disillusioned by the outcome of Wednesday's riots and are now losing faith in their leader.

MORE International ARTICLES

Antibody drugs are no cure but seem promising for COVID-19

Antibody drugs are no cure but seem promising for COVID-19
Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines mimic an infection to spur antibody production.

Antibody drugs are no cure but seem promising for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19
Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Lilly seeks emergency use of its antibody drug for COVID-19

Experts call Trump's rosy virus message misguided

Experts call Trump's rosy virus message misguided
The seven-day rolling average for new U.S. cases has climbed over the past two weeks to almost 42,000 per day. The nation also sees more than 700 COVID-19 deaths each day.

Experts call Trump's rosy virus message misguided

With Trump sick, all eyes on Wednesday's VP debate

With Trump sick, all eyes on Wednesday's VP debate
Questions persist about Donald Trump's health following his COVID-19 diagnosis, as well as the age of 77-year-old challenger Joe Biden.

With Trump sick, all eyes on Wednesday's VP debate

Magnitsky sanctions demanded in Iranian shootdown

Magnitsky sanctions demanded in Iranian shootdown
There were 176 people killed when the Iranian military shot down Ukraine International Airlines Flight PS752 on Jan. 8, shortly after it took off from Tehran.

Magnitsky sanctions demanded in Iranian shootdown

Berry scare: U.S. eyeing foreign produce imports

Berry scare: U.S. eyeing foreign produce imports
U.S. Trade Representative Robert Lighthizer served notice last week that the Trump administration fears domestic producers are being unfairly harmed by what they call a recent increase in berry imports from Canada and Mexico.

Berry scare: U.S. eyeing foreign produce imports